Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0M8T0
|
Suppression of tumorigenicity 7, isoform a; Suppressor of tumorigenicity 7 protein;
|
ST7;
|
NP_001162168.1;
|
554
|
cat
|
M3WJM0
|
Calcitonin; Uncharacterized protein;
|
LOC101094539; CALCA;
|
XP_003993065.1;
|
132
|
cat
|
B4XEM8
|
Dystroglycan 1; Uncharacterized protein;
|
DAG1;
|
NP_001124311.1;XP_006928808.1;
|
892
|
cat
|
M3W0N2
|
Histone H3;
|
H3F3B;
|
XP_003999137.1;
|
136
|
cat
|
M3WSK5
|
Uncharacterized protein;
|
LOC101095480;
|
XP_004001308.1;XP_004001317.1;
|
193
|
cat
|
Q6I748
|
Feline CD7; Uncharacterized protein;
|
fCD7; CD7;
|
NP_001009296.1;
|
210
|
cat
|
Q9GMZ8
|
B-lymphocyte activation antigen B7-1; CD80; Uncharacterized protein;
|
CD80;
|
NULL
|
292
|
cat
|
F8V3I9
|
Transcription elongation factor B polypeptide 1; Uncharacterized protein;
|
TCEB1;
|
NP_001233156.1;
|
112
|
cat
|
G4XSV9
|
Beta-hexosaminidase; EC 3.2.1.52;
|
HEXA;
|
NP_001265764.1;
|
529
|
cat
|
E1AB55
|
Keratin-71; Uncharacterized protein;
|
KRT71;
|
NP_001182168.1;
|
524
|
cat
|
M3WVP6
|
Histone H2B;
|
LOC101086477; H2BFS;
|
XP_003985735.1;XP_003985747.1;
|
126
|
cat
|
B3LF33
|
Nuclear transition protein 2;
|
Tnp2; TNP2;
|
XP_003998914.1;
|
119
|
cat
|
M3X0R4
|
Uncharacterized protein;
|
GNAQ;
|
XP_006939173.1;
|
301
|
cat
|
M3X085
|
Uncharacterized protein;
|
GLT8D2;
|
XP_003989236.1;XP_006934046.1;
|
350
|
cat
|
K4LND8
|
KIR2.1; Uncharacterized protein;
|
KCNJ2;
|
NULL
|
427
|
cat
|
F8V3I8
|
Transcription elongation factor B polypeptide 2; Uncharacterized protein;
|
TCEB2;
|
NP_001233157.1;
|
118
|
cat
|
M3X3R3
|
Ribonuclease A L1; Uncharacterized protein;
|
RNASE13; RAL1;
|
XP_003987448.1;
|
154
|
cat
|
F6K0R4
|
Lipid binding protein; Uncharacterized protein;
|
LOC100652387;
|
NP_001230012.1;
|
228
|
cat
|
M3WQD9
|
Cyclin-dependent kinase inhibitor 2A; Uncharacterized protein;
|
CDKN2A;
|
NP_001277177.1;
|
148
|
cat
|
M3X700
|
Histone H2A;
|
LOC101094019;
|
XP_003985754.1;XP_003985775.1;
|
130
|
cat
|